Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation TCT 2025

TCT 724: Impact of Access Route on TAVR Outcomes in Patients with Moderate to Severe Obesity and Low and Intermediate Surgical Risk: An STS/ACC TVT Registry Analysis

Presenter: Mansi Maini

October 27, 2025

Presentation TCT 2025

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Presenter: Raj Makkar

October 26, 2025

Presentation TCT 2025

TCT 637: The Impact of Frailty on Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair: A Report from the STS/TVT Registry®

Presenter: Michael Young

October 26, 2025

Presentation TCT 2025

TCT 226: Aspirin Versus Clopidogrel Following Transcatheter Aortic Valve Replacement: A TVT Registry Propensity Matched Analysis

Presenter: Yuri Pride

October 25, 2025

Presentation TCT 2025

TCT 826: Mitral Valve Gradient and Long-Term Outcomes Following Mitral Transcatheter Edge to Edge Repair in Patients with Severe Mitral Regurgitation: Results from 80,991 Patients in the STS/ACC TVT registry

Presenter: Arman Qamar

October 25, 2025

News Conference News NY Valves 2025

Promising Early Data With Navitor TAVI Valves

Yael L. Maxwell

July 02, 2025

News Conference News NY Valves 2025

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Yael L. Maxwell

June 30, 2025

Presentation NY Valves 2025

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

Presenter: Santiago Garcia

June 27, 2025

Presentation NY Valves 2025

Hospital Performance on 30-Day Readmissions After Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry

Presenter: Dhaval Kolte

June 26, 2025

Presentation NY Valves 2025

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

Presenter: David J. Cohen

June 25, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

News Conference News EuroPCR 2025

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Michael O'Riordan

May 21, 2025

News Conference News SCAI 2025

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

L.A. McKeown

May 02, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Daily News

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Caitlin E. Cox

March 25, 2025

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Michael O'Riordan

March 21, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

BIO

Advertisement

TCT 724: Impact of Access Route on TAVR Outcomes in Patients with Moderate to Severe Obesity and Low and Intermediate Surgical Risk: An STS/ACC TVT Registry Analysis

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

TCT 637: The Impact of Frailty on Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair: A Report from the STS/TVT Registry®

TCT 226: Aspirin Versus Clopidogrel Following Transcatheter Aortic Valve Replacement: A TVT Registry Propensity Matched Analysis

TCT 826: Mitral Valve Gradient and Long-Term Outcomes Following Mitral Transcatheter Edge to Edge Repair in Patients with Severe Mitral Regurgitation: Results from 80,991 Patients in the STS/ACC TVT registry

Promising Early Data With Navitor TAVI Valves

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

Hospital Performance on 30-Day Readmissions After Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

Wayne Batchelor, MD, MHS, MBA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content